oxaliplatin
This drug is selected. Its supporting articles are shown below.
Articles mentioning oxaliplatin
40 articles · page 1 of 4…city, with G3/4 events reported in 22% compared with 14% in the nivolumab monotherapy arm. An update presented at the European Society of…
… HCT116 cells treated with Ri plus chemotherapy (5-FU 40 mg/kg; oxaliplatin 7.5 mg/kg). Tumour burden, tumour multiplicity, and apoptosis (…
…ng to senescence escape. Pharmacological targeting of M7CK with MK-1602 (a novel inhibitor identified by virtual screening, KD = 6.49 μ…
…inuation because of its correlation with the cumulative dose of oxaliplatin. Currently, effective preventive measures are unavailable. Howe…
… container Withdrawal force (Kg) (SD) Insertion force (Kg) (SD) Oxaliplatin (100 mg/20 mL) 200 40 50 IV bag 4.22 (1.60) 5.80 (2.71) Oxalipl…
…, 48.7% (19) started fluoropyrimidines: 52.6% (10) started with capecitabine, 26.3% (five) combined with oxaliplatin, 15.8% (three) started …
…BTC were enrolled from five centers in China. Patients received pembrolizumab (200 mg, every 3 weeks), lenvatinib (8 or 12 mg daily), and mod…
…c MGMT-deficient G1/G2 PanNET treated with TMZ, with or without capecitabine, reportedly experienced histological progression to G3 disease …
… in increased ATP release and calreticulin exposure compared to cisplatin.Conclusions We show the syngeneic orthotopic model of TNBC is a…
…cer, although there remains a need for improvement in efficacy. Fruquintinib, an oral and highly selective vascular endothelial growth facto…
…by body surface area). HER2-positive patients will also receive trastuzumab. Primary endpoint: 1-year overall survival. Secondary endpoints…